Germany A summary of some of the top stories coming out of Germany’s biopharma industry, including Bayer’s EMA win for its Eylea eye therapy; the oncology deal Merck KGaA has cut with SpringWorks Therapeutics; the bispecific antibody alliance between BMS and BioNTech, and Sartorius’ acquisition of microtissue firm MatTek. Bayer…
Germany A roundup of some of the biggest stories coming out of German pharma, including Merck’s better-than-expected Q1 earnings; Stada’s possible return to the stock market; CDMO Vetter’s expanded capacity in the US and Germany; Bayer’s elimination of some 1,500 jobs, and BioNTech’s bid for MediLink’s solid tumour platform. Merck…
Puerto Rico In June 2019, Sartorius Stedim Biotech inaugurated the USD 130 million expansion of its Yauco site, one of the first multi-million dollar investment projects on the island after Hurricane Maria. Dante Castillo, the Yauco site’s director of operations, explains how this expansion fits within the group’s global ambitions and what…
See our Cookie Privacy Policy Here
